Pathologic complete response (pCR) was achieved in 63 out of 165 patients (38%) receiving neoadjuvant chemotherapy: 10 patients with ER low positive BC (10/24, 44%) and 53 patients with ER-negative BC (53/141, 38%). The gene discussed is ESR1; the disease is breast cancer.